A 4% albumin solution for priming and perioperative IV volume replacement solution in CABG did not reduce risk for 90-day major adverse events compared with standard Ringer’s acetate solution, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback